Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease
Journal Article
Overview
publication date
has subject area
-
Amyloidogenic Proteins - Amyloid beta-Peptides
-
Animal Diseases - Disease Models, Animal
-
Animal Population Groups - Animals, Genetically Modified
-
Animals
-
Brain Diseases - Alzheimer Disease
-
Caenorhabditis elegans
-
Central Nervous System Agents - Neuroprotective Agents
-
Clioquinol
-
Humans
-
Investigative Techniques - Drug Evaluation, Preclinical
-
Investigative Techniques - Drug Evaluation, Preclinical
-
Membrane Proteins - Amyloid beta-Peptides
-
Models, Animal - Disease Models, Animal
-
Models, Biological - Disease Models, Animal
-
Neurocognitive Disorders - Alzheimer Disease
-
Organisms, Genetically Modified - Animals, Genetically Modified
-
Peptides - Amyloid beta-Peptides
-
Physiological Effects of Drugs - Neuroprotective Agents
-
Tauopathies - Alzheimer Disease
has restriction
Date in CU Experts
-
September 3, 2013 2:53 AM
Full Author List
-
McColl G; Roberts BR; Pukala TL; Kenche VB; Roberts CM; Link CD; Ryan TM; Masters CL; Barnham KJ; Bush AI
author count
citation count
published in
Other Profiles
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
volume
number